# JBT Marel Corporation (JBTM) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Industrials / Machinery. Price $117.72, market value $6.1 billion.

## Valuation
- **P/E (trailing): 31.7×** (5-yr avg 28.8×, 3-yr avg 26.6×). JBT Marel Corporation trades at 31.7× trailing earnings, close to its own five-year average of 28.8×. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 12.7×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 1.6×**. Each dollar of revenue is priced at 1.6×.
- **Price / book: 1.4×**. The shares trade at 1.4× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 5.1%** (5-yr avg 2.8%). Free cash flow equals 5.1% of the market value, above its five-year average of 2.8%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 3.2%**. The inverse of the P/E: 3.2% of the price is earned each year.

## Profitability
- **Operating margin: 7.3%**. 7.3% of revenue is left after running the business.
- **Net margin: -1.3%**. The company reported a net loss over the last twelve months.
- **Return on equity: -1.1%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 3.7%**. Return on all capital, debt included, is 3.7%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 2.3%**. Each dollar of assets produces 2.3% of profit.

## Growth
- **Revenue growth (1 yr): 121.3%** (3-yr 33.7%/yr, 5-yr 17.1%/yr). Revenue grew 121.3% over the last year, against 17.1% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -137.0%**. Earnings per share fell 137.0%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 60.4%/yr**. Free cash flow has compounded at 60.4% a year over three years.

## Financial health
- **Debt to equity: 0.42**. Debt is 0.42 times equity: a conservative balance sheet.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 0.34%** ($0.40 per share, trailing). JBT Marel Corporation yields 0.34%, a modest yield more typical of a growth-oriented payer.
- **Consecutive years of increases: 18**. 18 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 0.0%/yr** (1-yr 0.0%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (7 analysts). 7 analysts cover JBT Marel Corporation; the consensus is buy, with an average price target of $171.93 (+46% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -16.8%** (YTD -21.8%, 3-mo -5.1%). The shares are down 16.8% over twelve months including dividends.
- **From 52-week high: -30.8%** (4.0% above the low). Trading 31% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 42**. An RSI of 42 is neutral.
- **Beta (1 yr): 1.07** (volatility 38%). Beta of 1.07 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=JBTM · Page: https://foliofundamentals.com/stocks/jbtm

Not investment advice.